Skip to main content
Main navigation
About Us
Leadership
Our People
Careers
Memberships
Therapeutic Areas
Infectious Diseases
Oncology
Internal Medicine
CNS & Pain
Respiratory
Services
Translational Medicine
Rare Diseases & Advanced Therapeutics
Medical Affairs
Portfolio Management and Commercial Strategy
Clinical Development and Operations
Regulatory and Peri-registration Activities
Drug Safety, PV and Risk Management
Virtual Offerings and Medical Affairs
Resources
News and Articles
Webinars
Newsletters
Congresses & Events
Brochures
tranScrip Social
Contact Us
Toggle navigation
Main navigation
About Us
Leadership
Our People
Careers
Memberships
Therapeutic Areas
Infectious Diseases
Oncology
Internal Medicine
CNS & Pain
Respiratory
Services
Translational Medicine
Rare Diseases & Advanced Therapeutics
Medical Affairs
Portfolio Management and Commercial Strategy
Clinical Development and Operations
Regulatory and Peri-registration Activities
Drug Safety, PV and Risk Management
Virtual Offerings and Medical Affairs
Resources
News and Articles
Webinars
Newsletters
Congresses & Events
Brochures
tranScrip Social
Contact Us
News and Articles
Pagination
First page
« First
Previous page
‹‹
Page
2
Current page
3
Page
4
Page
5
Next page
››
Last page
last
COVID-19 Hydroxychloroquine - Is it all over?
07 July 2020
Clinical Impact of COVID-19 on Cancer Treatment
24 June 2020
The Current State of Affairs in Antibiotic R&D published by ACS Infectious Diseases
23 June 2020
The Academy of Medical Sciences' COVID-19 UK Rapid Response Project Goes Live
15 June 2020
COVID-19 Panel Discussion: Successful Medical Affairs in the “New Normal” after COVID-19
11 June 2020
Another string to Recarbrio’s bow in the fight against antibiotic-resistance
11 June 2020
Clinical Impact of COVID-19 on Patients with Cancer
10 June 2020
The new, “pandemic proof” world. Is it new or is COVID-19 just driving trends faster?
09 June 2020
COVID-19: Developing Drugs and Biological Products for Treatment or Prevention - Background and New FDA Guidance
20 May 2020
COVID-19 Panel Discussion: Navigating translational/early clinical development during COVID-19
14 May 2020
Pagination
First page
« First
Previous page
‹‹
Page
2
Current page
3
Page
4
Page
5
Next page
››
Last page
last